WaveMan · Form 4
Foletta Mark G insider trades
> Search tickers & screens ⌘K
LIVE

Foletta Mark G insider trades

Foletta Mark G has filed 32 Form 4s with the SEC that we hold, for Dexcom INC (DXCM) (Director), Amn Healthcare Services INC (AMN) (Director) and Enanta Pharmaceuticals INC (ENTA) (Director). Across all of them we count 1 purchase worth $28.4K and 45 sales worth $3.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($741.6K). The largest single trade was a sale of 4,989 shares of Amn Healthcare Services INC worth $420.5K, dated 2023-04-11. The first filing on our record is dated 2021-10-05 and the latest 2026-08-04.

Dexcom INC (DXCM)

Director · 16 filings · 40 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-10-01S, sale reported on Form 447$25.3K2021-10-05
2021-10-01S, sale reported on Form 46$3.2K2021-10-05
2021-10-01S, sale reported on Form 488$47.6K2021-10-05
2021-10-01S, sale reported on Form 41$5522021-10-05
2021-10-01S, sale reported on Form 4181$98.5K2021-10-05
2021-10-01S, sale reported on Form 451$27.9K2021-10-05
2021-10-01S, sale reported on Form 4126$68.4K2021-10-05
2021-11-01S, sale reported on Form 443$26.8K2021-11-02
2021-11-01S, sale reported on Form 4124$77.5K2021-11-02
2021-11-01S, sale reported on Form 47$4.4K2021-11-02
2021-11-01S, sale reported on Form 476$47.8K2021-11-02
2021-11-01S, sale reported on Form 442$26.4K2021-11-02
2021-11-01S, sale reported on Form 440$25.3K2021-11-02
2021-11-01S, sale reported on Form 440$25.4K2021-11-02
2021-11-01S, sale reported on Form 413$8.1K2021-11-02
2021-11-01S, sale reported on Form 414$8.7K2021-11-02
2021-11-01S, sale reported on Form 445$27.7K2021-11-02
2021-11-01S, sale reported on Form 456$35.2K2021-11-02
2021-12-01S, sale reported on Form 4116$65.3K2021-12-02
2021-12-01S, sale reported on Form 441$22.8K2021-12-02
2021-12-01S, sale reported on Form 470$39.1K2021-12-02
2021-12-01S, sale reported on Form 478$43.8K2021-12-02
2021-12-01S, sale reported on Form 441$23.4K2021-12-02
2021-12-01S, sale reported on Form 465$36.7K2021-12-02
2021-12-01S, sale reported on Form 487$49.2K2021-12-02
2021-12-01S, sale reported on Form 42$1.1K2021-12-02
2024-06-17S, sale reported on Form 4475$55.9K2024-06-20
2024-06-17S, sale reported on Form 42,212$259.2K2024-06-20
2024-06-17S, sale reported on Form 47$8062024-06-20
2024-06-18S, sale reported on Form 4299$35.1K2024-06-20
2024-06-18S, sale reported on Form 43,007$351.1K2024-06-20
2025-06-16S, sale reported on Form 42,750$228.6K2025-06-18
2025-07-15S, sale reported on Form 48$6882025-07-17
2025-07-15S, sale reported on Form 42,742$233.5K2025-07-17
2025-08-15S, sale reported on Form 4195$15.9K2025-08-18
2025-08-15S, sale reported on Form 42,555$207.0K2025-08-18
2026-06-15S, sale reported on Form 4199$14.9K2026-06-17
2026-06-15S, sale reported on Form 43,801$281.7K2026-06-17
2026-07-31S, sale reported on Form 42,000$160.0K2026-08-04
2026-08-03S, sale reported on Form 42,000$170.6K2026-08-04

Amn Healthcare Services INC (AMN)

Director · 11 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-04-11S, sale reported on Form 44,989$420.5K2023-04-13
2023-04-11S, sale reported on Form 41,053$89.1K2023-04-13
2023-04-21S, sale reported on Form 41,458$129.4K2023-04-25
2024-02-29P, purchase reported on Form 4500$28.4K2024-03-01
2026-06-15S, sale reported on Form 41,681$52.2K2026-06-17
2026-06-15S, sale reported on Form 42,000$62.1K2026-06-17

Enanta Pharmaceuticals INC (ENTA)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1236389) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms